NCT06572618 2026-03-13Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell LymphomaCity of Hope Medical CenterPhase 2 Recruiting27 enrolled
NCT03267433 2026-03-02Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete RemissionEastern Cooperative Oncology GroupPhase 3 Active not recruiting689 enrolled